Emerging findings suggest that Retatrutide , a dual stimulator targeting incretin and gastric inhibitory peptide pathways , appears to be a progress for weight control . Preliminary patient data https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026